Home › Chronic-Phase Myeloid Leukemia › Texas › Houston
Chronic-Phase Myeloid Leukemia clinical trials in Houston, TX
5 studies for Chronic-Phase Myeloid Leukemia are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
RecruitingPhase 2
- M D Anderson Cancer Center, Houston
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RecruitingPhase 3
- Ascentage Investigative Site #1501, Houston
Personalized NK Cell Therapy in CBT
RecruitingPhase 2
- M D Anderson Cancer Center, Houston
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RecruitingPhase 1/2
- The University of Texas M.D. Anderson Cancer Center, Houston
Chronic-Phase Myeloid Leukemia trials in other cities
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.